These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6698110)

  • 21. Protective actions of naloxone in hemorrhagic shock.
    Curtis MT; Lefer AM
    Am J Physiol; 1980 Sep; 239(3):H416-21. PubMed ID: 7435587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of action of PGE1 in hemorrhagic shock in rats.
    Bitterman H; Stahl GL; Terashita Z; Lefer AM
    Ann Emerg Med; 1988 May; 17(5):457-62. PubMed ID: 3364825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation of the protective effects of a converting enzyme inhibitor and a thromboxane synthetase inhibitor in hemorrhagic shock.
    Bitterman H; Phillips GR; Dragon G; Lefer AM
    J Pharmacol Exp Ther; 1987 Jul; 242(1):8-14. PubMed ID: 3039116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Large arteries in hypertension: acute effects of a new calcium entry blocker, nitrendipine.
    Levenson J; Simon AC; Safar ME; Bouthier J; Maarek BC
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1006-10. PubMed ID: 6085357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parallel reduction of calcium-influx-dependent vasoconstriction and platelet-free calcium concentration with calcium entry and beta-adrenoceptor blockade.
    Bolli P; Erne P; Hulthén UL; Ritz R; Kiowski W; Ji BH; Bühler FR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S996-1001. PubMed ID: 6085391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel mechanism of action of a prostacyclin enhancing agent in haemorrhagic shock.
    Bitterman H; Lefer DJ; Lefer AM
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):679-86. PubMed ID: 3063971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salutary effects of anisodamine in murine traumatic shock.
    Hock CE; Su JY; Lefer AM
    Circ Shock; 1983; 11(3):211-6. PubMed ID: 6652878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restoration of renal and mesenteric hemodynamics by felodipine in a canine model of hemorrhagic shock.
    Sabouni M; Hodge K; Jandhyala BS
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):465-70. PubMed ID: 3405320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amelioration of splanchnic artery occlusion (SAO) shock by cysteine.
    Galvin MJ; Lefer AM
    Adv Shock Res; 1978; 1():261-70. PubMed ID: 262085
    [No Abstract]   [Full Text] [Related]  

  • 30. Protective effects of CG-4203, a novel stable prostacyclin analog, in traumatic shock.
    Bitterman H; Stahl GL; Lefer AM
    Prostaglandins; 1988 Jan; 35(1):41-50. PubMed ID: 3287456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arachidonic acid in splanchnic artery occlusion shock.
    Bridenbaugh GA; Flynn JT; Lefer AM
    Am J Physiol; 1976 Jul; 231(1):112-9. PubMed ID: 961849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a new calcium antagonist, nitrendipine, on blood pressure and heart rate of conscious, unrestrained dogs.
    Knorr A; Stoepel K
    Arzneimittelforschung; 1981; 31(12):2062-4. PubMed ID: 7199298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a calcium entry blocker on blood pressure and renal function during angiotensin-induced hypertension.
    Huelsemann JL; Sterzel RB; McKenzie DE; Wilcox CS
    Hypertension; 1985; 7(3 Pt 1):374-9. PubMed ID: 3158602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shock potentiating actions of angiotensin II infusion in cats.
    Trachte GJ; Lefer AM
    Circ Shock; 1980; 7(3):343-51. PubMed ID: 7449049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuation of hemorrhagic shock by the non-glucocorticoid 21-aminosteroid U74006F.
    Hall ED; Yonkers PA; McCall JM
    Eur J Pharmacol; 1988 Mar; 147(2):299-303. PubMed ID: 3366180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitrendipine reverses vasoconstriction and renal hemodynamic changes in experimental hypertension.
    Sterzel RB; Huelsemann JL; McKenzie DE; Wilcox CS
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1024-7. PubMed ID: 6085360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Store-operated calcium channel inhibition attenuates neutrophil function and postshock acute lung injury.
    Lee C; Xu DZ; Feketeova E; Kannan KB; Fekete Z; Deitch EA; Livingston DH; Hauser CJ
    J Trauma; 2005 Jul; 59(1):56-63; discussion 63. PubMed ID: 16096539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of the novel cardiotonic and vasodilator agent pimobendan in traumatic shock.
    Bitterman H; Smith BA; Lefer AM
    Arzneimittelforschung; 1988 Oct; 38(10):1389-93. PubMed ID: 3196378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-shock effects of human superoxide dismutase in splanchnic artery occlusion (SAO) shock.
    Bitterman H; Aoki N; Lefer AM
    Proc Soc Exp Biol Med; 1988 Jul; 188(3):265-71. PubMed ID: 3393543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.